Skip to main content Skip to main content
Go to homepage

Pregabalin for Children 1 mo to 16 years with seizures

Safety and Efficacy of Pregabalin in Children Aged 1 mo to 16 years with Seizures


For complete information, please view the study on

Study Status:
Full IRB Study Title:
A 12-month Open-label Study To Evaluate The Safety And Tolerability Of Pregabalin As Adjunctive Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-clonic Seizures
IRB Study ID:
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email
Lead Investigator
Michael Kohrman, MD

Director, Pediatric Neurology; Pediatric Neurologist
Pediatric Epilepsy ProgramTuberous Sclerosis ClinicNeuroDevelopmental Science Center

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.